Have a personal or library account? Click to login
The influence of genetic variability on the risk of developing malignant mesothelioma Cover

The influence of genetic variability on the risk of developing malignant mesothelioma

Open Access
|Jan 2018

References

  1. Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin 2004; 14: 469-77. 10.1016/j.thorsurg.2004.06.01115559053
  2. Franko A, Dolzan V, Kovac V, Arneric N, Dodic-Fikfak M. Soluble mesothelin-related peptides levels in patients with malignant mesothelioma. Dis Markers 2012; 32: 123-31. 10.3233/DMA-2011-086622377706
  3. Burdorf A, Dahhan M, Swuste P. Occupational characteristics of cases with asbestos-related diseases in the Netherlands. Ann Occup Hyg 2003; 47: 485-92. 10.1093/annhyg/meg062
  4. Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. MedGenMed 2007; 9: 32.17955087
  5. O’Reilly KM, Mclaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. Am Fam Physician 2007; 75: 683-90.17375514
  6. Plato N, Martinsen JI, Sparen P, Hillerdal G, Weiderpass E. Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban. Epidemiol Health 2016; 38: e2016039. 10.4178/epih.e201603927866405
  7. Aung W, Hasegawa S, Furukawa T, Saga T. Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis. Carcinogenesis 2007; 28: 2047-52. 10.1093/carcin/bgm09017434931
  8. Liu G, Cheresh P, Kamp DW. Molecular basis of asbestos-induced lung disease. Annu Rev Pathol 2013; 8: 161. 10.1146/annurev-pathol-020712-16394223347351
  9. Pietrofesa RA, Velalopoulou A, Albelda SM, Christofidou-Solomidou M. Asbestos induces oxidative stress and activation of Nrf2 signaling in murine macrophages: chemopreventive role of the synthetic lignan secoisolariciresinol diglucoside (LGM2605). Int J Mol Sci 2016; 17: 322. 10.3390/ijms1703032226938529
  10. Kinnula V. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J 1999; 14: 706-16.1054329710.1034/j.1399-3003.1999.14c35.x
  11. Weitzman SA, Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 1984; 228: 373-6. https://doi.org/10.1016/0003-9861(84)90078-x
  12. Pezerat H, Zalma R, Guignard J, Jaurand M. Production of oxygen radicals by the reduction of oxygen arising from the surface activity of mineral fibres. IARC Sci Publ 1988; (90): 100-11.
  13. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 2003; 34: 1117-29. https://doi.org/10.1016/s0891-5849(03)00060-11270649210.1016/S0891-5849(03)00060-1
  14. Forsberg L, Lyrenäs L, Morgenstern R, de Faire U. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-5. https://doi.org/10.1016/s0891-5849(00)00487-110.1016/S0891-5849(00)00487-1
  15. Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, et al. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 1082-7. 10.1158/1055-9965.EPI-07-275518483329
  16. Franko A, Dolžan V, Arnerić N, Dodič-Fikfak M. Asbestosis and catalase genetic polymorphism. Arh Hig Rada Toksikol 2008; 59: 233-40. 10.2478/10004-1254-59-2008-190719064360
  17. Chuang T-C, Liu J-Y, Lin C-T, Tang Y-T, Yeh M-H, Chang S-C, et al. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy. FEBS Lett 2007; 581: 4443-9. 10.1016/j.febslet.2007.08.02117719580
  18. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 2003; 63: 1297-303.12649190
  19. Li H, Hao X, Zhang W, Wei Q, Chen K. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 1739-45. 10.1158/1055-9965.EPI-08-0001
  20. Zhong D, Li G, Long J, Wu J, Hu Y. The hOGG1Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians: an updated metaanalysis. Sci Rep 2012; 2: 548. 10.1038/srep00548
  21. Chao C, Zhang Z-F, Berthiller J, Boffetta P, Hashibe M. NAD (P) H: quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 979-87. 10.1158/1055-9965.EPI-05-0899
  22. Basma HA, Kobeissi LH, Jabbour ME, Moussa MA, Dhaini HR. CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population. Int J Mol Epidemiol Genet 2013; 4: 207-17.
  23. Stoehr CG, Nolte E, Wach S, Wieland WF, Hofstaedter F, Hartmann A, et al. NAD (P) H: Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and prostate cancer risk in Caucasians. Int J Mol Sci 2012; 13: 10959-69. 10.3390/ijms130910959
  24. Gemignani F, Neri M, Bottari F, Barale R, Canessa PA, Canzian F, et al. Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. Mutat Res 2009; 671: 76-83. 10.1016/j.mrfmmm.2009.09.00319751749
  25. Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, et al. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer 2007; 120: 2739-43. 10.1002/ijc.2259017290392
  26. Kinnula VL, Torkkeli T, Kristo P, Sormunen R, Soini Y, Paakko P, et al. Ultrastructural and chromosomal studies on manganese superoxide dismutase in malignant mesothelioma. Am J Respir Cell Mol Biol 2004; 31: 147-53. 10.1165/rcmb.2003-0409OC15039138
  27. Franko A, Dolžan V, Arnerić N, Dodič-Fikfak M. The influence of gene-gene and gene-environment interactions on the risk of asbestosis. Biomed Res Int 2013; 2013: 1-7. 10.1155/2013/405743
  28. Franko A, Dodič-Fikfak M, Arnerić N, Dolžan V. Manganese and extracellular superoxide dismutase polymorphisms and risk for asbestosis. Biomed Res Int 2009; 2009: 1-6. 10.1155/2009/493083
  29. Fikfak MD, Kriebel D, Quinn M, Eisen E, Wegman D. A case control study of lung cancer and exposure to chrysotile and amphibole at a Slovenian asbestos-cement plant. Ann Occup Hyg 2007; 51: 261-8. 10.1093/annhyg/mem003
  30. Erčulj N, Kovač V, Hmeljak J, Dolžan V. The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma. Ann Oncol 2011; 23: 961-7. 10.1093/annonc/mdr32421765044
  31. Durham A, Adcock I. The relationship between COPD and lung cancer. Lung Cancer 2015; 90: 121-7. 10.1016/j.lungcan.2015.08.01726363803
  32. Harman D. Free radical theory of aging: an update. Ann N Y Acad Sci 2006; 1067: 10-21. 10.1196/annals.1354.00316803965
  33. Jung M, Davis WP, Taatjes DJ, Churg A, Mossman BT. Asbestos and cigarette smoke cause increased DNA strand breaks and necrosis in bronchiolar epithelial cells in vivo. Free Radic Biol Med 2000; 28: 1295-9. 10.1016/S0891-5849(00)00211-210889460
  34. Jackson J, Schraufstatter I, Hyslop P, Vosbeck K, Sauerheber R, Weitzman S, et al. Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest 1987; 80: 1090-5. 10.1172/JCI1131652821073
  35. Valavanidis A, Vlachogianni T, Fiotakis K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Env Res Public Health 2009; 6: 445-62. 10.3390/ijerph6020445
  36. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992; 12: 293-315.10.1016/0891-5849(92)90117-Y1577332
  37. Delgermaa V, Takahashi K, Park E-K, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 2011; 89: 716-24. 10.2471/BLT.11.08667822084509
  38. Tomasson K, Gudmundsson G, Briem H, Rafnsson V. Malignant mesothelioma incidence by nation-wide cancer registry: a population-based study. J Occup Med Toxicol 2016; 11: 1-6. 10.1186/s12995-016-0127-4
  39. Whitmer M. Mesothelioma latency period. 2016. Available at: https://www.asbestos.com/mesothelioma/latency-period.php. Accessed 25 Avg 2016.
  40. Hansen J, De Klerk NH, Eccles JL, William Musk A, Hobbs MS. Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer 1993; 54: 578-81. 10.1002/ijc.29105404108390408
  41. Armstrong B, De Klerk N, Musk A, Hobbs M. Mortality in miners and millers of crocidolite in Western Australia. Br J Ind Med 1988; 45: 5-13.2829959
  42. Ulvestad B, Kjærheim K, Martinsen JI, Damberg G, Wannag A, Mowe G, et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002; 28: 411-7. 10.5271/sjweh.69312539801
  43. Ulvestad B, Kjærheim K, Martinsen JI, Mowe G, Andersen A. Cancer incidence among members of the Norwegian trade union of insulation workers. J Occup Environ Med 2004; 46: 84-9. 10.1097/01.jom.0000105981.46987.4214724482
  44. Ding R, Lin S, Chen D. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 2012; 27: 885-92. 10.1007/s00384-011-1396-022215148
  45. Wang LI, Miller DP, Sai Y, Liu G, Su L, Wain JC, et al. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst 2001; 93: 1818-21.1173459910.1093/jnci/93.23.1818
  46. Zejnilovic J, Akev N, Yilmaz H, Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet 2009; 189: 1-4. 10.1016/j.cancergencyto.2008.06.01719167605
  47. Erčulj N, Zadel M, Dolžan V. Genetic polymorphisms in base excision repair in healthy slovenian population and their influence on DNA damage. Acta Chim Slov 2010; 57: 182-8.24061671
  48. Neri M, Filiberti R, Taioli E, Garte S, Paracchini V, Bolognesi C, et al. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat Res 2005; 592: 36-44. 10.1016/j.mrfmmm.2005.06.00315993904
DOI: https://doi.org/10.2478/raon-2018-0004 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 105 - 111
Submitted on: Sep 3, 2017
|
Accepted on: Sep 12, 2017
|
Published on: Jan 24, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Alenka Franko, Nika Kotnik, Katja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, Vita Dolzan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.